Surmodics (SRDX)
(Real Time Quote from BATS)
$34.28 USD
-0.99 (-2.81%)
Updated May 23, 2024 01:44 PM ET
1-Strong Buy of 5 1
D Value F Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Bottom 42% (144 out of 249)Zacks Sector Rank
Top 44% (7 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.50 | 1.69 | 9.99 |
Current Quarter Estimate | -0.30 | 5.88 | 57.00 |
Year Ago Quarter Estimate | 0.52 | 4.88 | 52.54 |
Next Quarter Estimate | -0.27 | 7.06 | 61.00 |
Next Year Estimate | -0.02 | 39.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -550.00 | 14.00 | 15.67 |
Next Year | 97.22 | 20.70 | 9.31 |
Last 5 Years | -22.90 | 3.90 | 8.10 |
Next 5 Years | NA | 12.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 31.49 | -13.85 |
Price/Book (MRQ) | 4.06 | 2.18 |
Price/Cash Flow (MRFY) | 44.98 | 11.64 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 9.44% | -10.23% |
Return on Equity (TTM) | 13.30% | -3.83% |
Debt to Equity (MRQ) | 0.24 | 20.61 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.